AFFY CEO is in panic mode, he sold a lot of shares and we have 3 deaths
Now, Affymax's future is in Takeda's hands.
I will start to worry when i won't see Omontys in Takeda's websites
visit Takeda 's web sites, clic on products:
Omontys is still a Takeda's " core product " , after deaths and recall.
remember:Takeda has 5.36B in cash, and is still investigating Omontys safety concerns
Omontys will be back to market in 2013